Publication Information

{'id': 'https://openalex.org/W3207213207', 'doi': 'https://doi.org/10.2147/dddt.s332026', 'title': 'The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study', 'display_name': 'The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study', 'publication_year': 2021, 'publication_date': '2021-10-01', 'ids': {'openalex': 'https://openalex.org/W3207213207', 'doi': 'https://doi.org/10.2147/dddt.s332026', 'mag': '3207213207', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/34703212', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/8526518'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2147/dddt.s332026', 'pdf_url': 'https://www.dovepress.com/getfile.php?fileID=74980', 'source': {'id': 'https://openalex.org/S2496126384', 'display_name': 'Drug Design Development and Therapy', 'issn_l': '1177-8881', 'issn': ['1177-8881'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320348', 'host_organization_name': 'Dove Medical Press', 'host_organization_lineage': ['https://openalex.org/P4310320348'], 'host_organization_lineage_names': ['Dove Medical Press'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'doaj', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://www.dovepress.com/getfile.php?fileID=74980', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5046162184', 'display_name': 'David P. Walling', 'orcid': 'https://orcid.org/0000-0001-8638-2086'}, 'institutions': [{'id': 'https://openalex.org/I4210129757', 'display_name': 'Collaborative Neuroscience Network', 'ror': 'https://ror.org/034a8v770', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210129757']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David P Walling', 'raw_affiliation_strings': ['Collaborative Neuroscience Network, LLC Garden Grove, Garden Grove, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Collaborative Neuroscience Network, LLC Garden Grove, Garden Grove, CA, USA', 'institution_ids': ['https://openalex.org/I4210129757']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111638808', 'display_name': 'Howard A Hassman', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210110205', 'display_name': 'Hassman Research Institute', 'ror': 'https://ror.org/01zmatx12', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210110205']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Howard A Hassman', 'raw_affiliation_strings': ['Hassman Research Institute, Berlin, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'Hassman Research Institute, Berlin, NJ, USA', 'institution_ids': ['https://openalex.org/I4210110205']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012684643', 'display_name': 'Lourdes Anta', 'orcid': 'https://orcid.org/0000-0001-5981-1850'}, 'institutions': [{'id': 'https://openalex.org/I4210089961', 'display_name': 'Laboratorios Farmaceúticos Rovi (Spain)', 'ror': 'https://ror.org/00fc1yz57', 'country_code': 'ES', 'type': 'company', 'lineage': ['https://openalex.org/I4210089961']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Lourdes Anta', 'raw_affiliation_strings': ['Medical Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Medical Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089961']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055728132', 'display_name': 'Lourdes Ochoa', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210089961', 'display_name': 'Laboratorios Farmaceúticos Rovi (Spain)', 'ror': 'https://ror.org/00fc1yz57', 'country_code': 'ES', 'type': 'company', 'lineage': ['https://openalex.org/I4210089961']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Lourdes Ochoa', 'raw_affiliation_strings': ['R&D Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'R&D Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089961']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000848927', 'display_name': 'I. Ayani', 'orcid': 'https://orcid.org/0000-0001-7654-3763'}, 'institutions': [{'id': 'https://openalex.org/I4210089961', 'display_name': 'Laboratorios Farmaceúticos Rovi (Spain)', 'ror': 'https://ror.org/00fc1yz57', 'country_code': 'ES', 'type': 'company', 'lineage': ['https://openalex.org/I4210089961']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Ignacio Ayani', 'raw_affiliation_strings': ['Medical Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Medical Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089961']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014324002', 'display_name': 'Javier Martínez', 'orcid': 'https://orcid.org/0000-0001-6314-4480'}, 'institutions': [{'id': 'https://openalex.org/I4210089961', 'display_name': 'Laboratorios Farmaceúticos Rovi (Spain)', 'ror': 'https://ror.org/00fc1yz57', 'country_code': 'ES', 'type': 'company', 'lineage': ['https://openalex.org/I4210089961']}], 'countries': ['ES'], 'is_corresponding': True, 'raw_author_name': 'Javier Martínez', 'raw_affiliation_strings': ['Medical Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Medical Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089961']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5067167326', 'display_name': 'I. Gutierro', 'orcid': 'https://orcid.org/0000-0002-7533-9194'}, 'institutions': [{'id': 'https://openalex.org/I4210089961', 'display_name': 'Laboratorios Farmaceúticos Rovi (Spain)', 'ror': 'https://ror.org/00fc1yz57', 'country_code': 'ES', 'type': 'company', 'lineage': ['https://openalex.org/I4210089961']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Ibon Gutierro', 'raw_affiliation_strings': ['R&D Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'R&D Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089961']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': ['https://openalex.org/A5014324002'], 'corresponding_institution_ids': ['https://openalex.org/I4210089961'], 'apc_list': {'value': 2836, 'currency': 'USD', 'value_usd': 2836, 'provenance': 'doaj'}, 'apc_paid': {'value': 2836, 'currency': 'USD', 'value_usd': 2836, 'provenance': 'doaj'}, 'fwci': 1.786, 'has_fulltext': False, 'cited_by_count': 10, 'citation_normalized_percentile': {'value': 0.999921, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 87, 'max': 88}, 'biblio': {'volume': 'Volume 15', 'issue': None, 'first_page': '4371', 'last_page': '4382'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11123', 'display_name': 'Obsessive-Compulsive Spectrum Disorders', 'score': 0.9873, 'subfield': {'id': 'https://openalex.org/subfields/3203', 'display_name': 'Clinical Psychology'}, 'field': {'id': 'https://openalex.org/fields/32', 'display_name': 'Psychology'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T10854', 'display_name': 'Bipolar Disorder and Treatment', 'score': 0.9818, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/paliperidone-palmitate', 'display_name': 'Paliperidone Palmitate', 'score': 0.5784844}, {'id': 'https://openalex.org/keywords/dopamine-antagonist', 'display_name': 'Dopamine antagonist', 'score': 0.56644434}], 'concepts': [{'id': 'https://openalex.org/C2780057945', 'wikidata': 'https://www.wikidata.org/wiki/Q412443', 'display_name': 'Risperidone', 'level': 3, 'score': 0.9721819}, {'id': 'https://openalex.org/C2908997079', 'wikidata': 'https://www.wikidata.org/wiki/Q27157250', 'display_name': 'Paliperidone Palmitate', 'level': 4, 'score': 0.5784844}, {'id': 'https://openalex.org/C181389837', 'wikidata': 'https://www.wikidata.org/wiki/Q461809', 'display_name': 'Bioavailability', 'level': 2, 'score': 0.57003284}, {'id': 'https://openalex.org/C2781353949', 'wikidata': 'https://www.wikidata.org/wiki/Q3271533', 'display_name': 'Dopamine antagonist', 'level': 4, 'score': 0.56644434}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.52242225}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4931633}, {'id': 'https://openalex.org/C2777056448', 'wikidata': 'https://www.wikidata.org/wiki/Q285166', 'display_name': 'Oral administration', 'level': 2, 'score': 0.47618833}, {'id': 'https://openalex.org/C2776921671', 'wikidata': 'https://www.wikidata.org/wiki/Q758295', 'display_name': 'Atypical antipsychotic', 'level': 4, 'score': 0.41625106}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.4025575}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.39915115}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.35872856}, {'id': 'https://openalex.org/C42219234', 'wikidata': 'https://www.wikidata.org/wiki/Q131130', 'display_name': 'Anesthesia', 'level': 1, 'score': 0.32215312}, {'id': 'https://openalex.org/C2776412080', 'wikidata': 'https://www.wikidata.org/wiki/Q7431605', 'display_name': 'Schizophrenia (object-oriented programming)', 'level': 2, 'score': 0.21546048}, {'id': 'https://openalex.org/C2780494398', 'wikidata': 'https://www.wikidata.org/wiki/Q208144', 'display_name': 'Antipsychotic', 'level': 3, 'score': 0.18038455}, {'id': 'https://openalex.org/C2780948584', 'wikidata': 'https://www.wikidata.org/wiki/Q251347', 'display_name': 'Haloperidol', 'level': 3, 'score': 0.16284001}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.1576786}, {'id': 'https://openalex.org/C513476851', 'wikidata': 'https://www.wikidata.org/wiki/Q170304', 'display_name': 'Dopamine', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D019540', 'descriptor_name': 'Area Under Curve', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001682', 'descriptor_name': 'Biological Availability', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003692', 'descriptor_name': 'Delayed-Action Preparations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004343', 'descriptor_name': 'Drug Implants', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005500', 'descriptor_name': 'Follow-Up Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013810', 'descriptor_name': 'Therapeutic Equivalency', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 5, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.2147/dddt.s332026', 'pdf_url': 'https://www.dovepress.com/getfile.php?fileID=74980', 'source': {'id': 'https://openalex.org/S2496126384', 'display_name': 'Drug Design Development and Therapy', 'issn_l': '1177-8881', 'issn': ['1177-8881'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320348', 'host_organization_name': 'Dove Medical Press', 'host_organization_lineage': ['https://openalex.org/P4310320348'], 'host_organization_lineage_names': ['Dove Medical Press'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://doaj.org/article/a256d4300d484f2c90cfa6b6c8041253', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306401280', 'display_name': 'DOAJ (DOAJ: Directory of Open Access Journals)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc8526518', 'pdf_url': 'https://europepmc.org/articles/pmc8526518?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526518', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/34703212', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.2147/dddt.s332026', 'pdf_url': 'https://www.dovepress.com/getfile.php?fileID=74980', 'source': {'id': 'https://openalex.org/S2496126384', 'display_name': 'Drug Design Development and Therapy', 'issn_l': '1177-8881', 'issn': ['1177-8881'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320348', 'host_organization_name': 'Dove Medical Press', 'host_organization_lineage': ['https://openalex.org/P4310320348'], 'host_organization_lineage_names': ['Dove Medical Press'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.58, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 21, 'referenced_works': ['https://openalex.org/W1980466924', 'https://openalex.org/W1992457778', 'https://openalex.org/W1999689270', 'https://openalex.org/W2009652756', 'https://openalex.org/W2037386295', 'https://openalex.org/W2061211518', 'https://openalex.org/W2089315440', 'https://openalex.org/W2096271865', 'https://openalex.org/W2126097234', 'https://openalex.org/W2138959943', 'https://openalex.org/W2162814669', 'https://openalex.org/W2165379748', 'https://openalex.org/W2174934002', 'https://openalex.org/W2219812044', 'https://openalex.org/W2464467657', 'https://openalex.org/W2527103551', 'https://openalex.org/W2767770516', 'https://openalex.org/W2957311488', 'https://openalex.org/W3083432627', 'https://openalex.org/W3124121244', 'https://openalex.org/W4211262802'], 'related_works': ['https://openalex.org/W4300005642', 'https://openalex.org/W4240708589', 'https://openalex.org/W4205610953', 'https://openalex.org/W3184803136', 'https://openalex.org/W2802432955', 'https://openalex.org/W2127664594', 'https://openalex.org/W2110284416', 'https://openalex.org/W2097100909', 'https://openalex.org/W1964261496', 'https://openalex.org/W1483000871'], 'abstract_inverted_index': {'Introduction:': [0], 'This': [1], 'open-label,': [2], 'one-sequence': [3], 'study': [4], 'evaluated': [5], 'the': [6, 86, 92, 97, 157, 179, 182, 243, 261, 264, 272, 285, 308, 315], 'steady-state': [7, 59, 98, 134, 192, 273, 305], 'comparative': [8, 326], 'bioavailability': [9], 'of': [10, 32, 53, 77, 120, 144, 257, 263, 307], 'risperidone': [11, 20, 26, 37, 54, 69, 104, 114, 116, 145, 149, 160, 225, 232, 258, 276, 288, 291, 319], 'in': [12, 21, 85, 140, 242, 297], 'situ': [13], 'microimplants': [14], '(ISM': [15], '®': [16], ')': [17], 'and': [18, 68, 89, 126, 138, 167, 196, 216, 228, 239, 313], 'oral': [19, 25, 30, 113, 159, 224, 251, 275, 287, 318], 'patients': [22, 299], 'stabilized': [23, 249], 'on': [24], 'treatment.': [27, 277], 'Methods:': [28], 'Repeat': [29], 'administration': [31, 151], 'once': [33, 222, 229], 'daily': [34, 223], '4': [35, 44, 226], 'mg': [36, 227, 235], 'for': [38, 64, 96, 103, 112, 317, 335], '7': [39], 'days': [40], 'was': [41, 72], 'followed': [42], 'by': [43], 'monthly': [45, 230], '(once': [46], 'every': [47], 'four': [48], 'weeks)': [49], 'intramuscular': [50], '(IM)': [51], 'doses': [52], 'ISM': [55, 117, 150, 233, 259, 292], '100': [56, 234], 'mg.': [57], 'Mean': [58], 'concentration': [60, 132, 190, 199], 'versus': [61, 100, 115], 'time': [62, 101, 302], 'profiles': [63, 102], 'risperidone,': [65, 67, 332], '9-OH': [66], 'active': [70, 105, 146, 309], 'moiety': [71, 106, 147, 310], 'characterized.': [73], 'Results:': [74], 'A': [75], 'total': [76], '104': [78], 'subjects': [79, 245], 'were': [80, 83, 173, 202, 236], 'enrolled,': [81], '81': [82], 'included': [84], 'safety': [87], 'population': [88], '58': [90], 'completed': [91], 'study.': [93], 'Intersubject': [94], 'variability': [95, 110], 'concentrations': [99, 142], 'presented': [107], 'a': [108], 'greater': [109], 'range': [111], '(%': [118], 'coefficient': [119], 'variation': [121], '[CV]': [122], 'range:': [123], '40–': [124], '65%': [125], '38–': [127], '52%,': [128], 'respectively).': [129, 220], 'Minimum': [130], 'plasma': [131, 141, 189, 198], 'at': [133, 191, 271], '(C': [135, 193, 200], 'min,': [136], 'ss)': [137, 195], 'fluctuation': [139], '(Fluc)': [143], 'after': [148, 274, 281], 'met': [152], 'bioequivalence': [153], 'criteria': [154], 'compared': [155], 'to': [156, 268, 290], 'reference': [158], '(geometric': [161], 'mean': [162], 'ratio': [163], '[GMR]': [164], '=': [165, 209], '1.09': [166], '0.96,': [168], 'respectively;': [169], 'both': [170], '90%': [171], 'CIs': [172], 'within': [174], '0.80–': [175], '1.25).': [176], 'Area': [177], 'under': [178], 'curve': [180], 'during': [181], 'dosing': [183], 'interval': [184], '(AUC': [185], 'tau)': [186], ',': [187], 'maximum': [188], 'max,': [194], 'average': [197], 'ave)': [201], 'only': [203], 'slightly': [204], 'higher': [205], '(GMR': [206], '[90%': [207], 'CI]': [208], '1.25': [210, 217], '[1.16–': [211, 218], '1.34],': [212, 219], '1.17': [213], '[1.08–': [214], '1.27],': [215], 'Overall,': [221], 'IM': [231], 'generally': [237], 'safe': [238], 'well': [240], 'tolerated': [241], 'participating': [244], 'with': [246, 250, 300], 'schizophrenia': [247, 298, 333], 'previously': [248], 'risperidone.': [252], 'Conclusion:': [253], 'The': [254], 'rapid': [255], 'release': [256], 'allows': [260], 'achievement': [262], 'desired': [265], 'levels': [266, 306], 'similar': [267], 'those': [269], 'observed': [270], 'Therefore,': [278], 'direct': [279], 'switch': [280], '24': [282], 'hours': [283], 'from': [284], 'last': [286], 'dose': [289], 'treatment': [293, 312], 'can': [294], 'be': [295], 'done': [296], 'no': [301], 'lag,': [303], 'maintaining': [304], 'throughout': [311], 'without': [314], 'need': [316], 'supplementation': [320], 'or': [321], 'loading': [322], 'doses.': [323], 'Keywords:': [324], 'bioequivalence,': [325], 'bioavailability,': [327], 'long-acting': [328], 'injectables,': [329], 'LAIs,': [330], 'pharmacokinetic,': [331], 'Corrigendum': [334], 'this': [336], 'paper': [337], 'has': [338], 'been': [339], 'published': [340]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3207213207', 'counts_by_year': [{'year': 2024, 'cited_by_count': 5}, {'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}], 'updated_date': '2024-12-17T09:33:08.075768', 'created_date': '2021-10-25'}